In the Spotlight: Rajan Sharma.
Get to know our analyst team one at a time in our new exclusive interviews
Rajan Sharma was hired straight out of Oxford University in 2013 after he completed his Masters in Pharmacology. Rajan is our resident diabetes expert, producing and expanding our current diabetes type 1 and 2 content, which manages to keep him more than a little bit busy. We have put Rajan “In the Spotlight” to find out what makes him tick and what will keep him busy in 2015…
What is your background?
I did my undergraduate degree in biological science at the University of Liverpool , then I moved on to do my Masters in Pharmacology at Oxford. After I graduated from there in 2013 I started working here just a couple of months later.
What is your role here at Datamonitor Healthcare?
I’m a disease analyst and mostly cover the metabolic diseases . Mainly I work on diabetes so the type 2 diabetes content is where I spend most of my time and this year we’ll be working on building our type 1 diabetes. It’s quite a big area so it keeps me busy! It’s exciting because there are so many different drugs and market dynamics; it’s such a big area and really interesting.
Within these areas, what has been your most interesting research project?
I enjoyed working on the forecast, but it would probably be the treatment report because of the level of detail. We look at the market at a granular level and get a very good insight into physicians’ opinions so we can understand what influences market dynamics. Hopefully that’s useful to our clients as well!
What do you like most about working at Datamonitor Healthcare?
I enjoy that we are able to combine the science of the industry with the commercial aspect. So we look at drugs from both perspectives: we use clinical data and research papers to keep up to date with the drug development and also analyse the commercial factors which influence products and disease areas.
I would definitely say the team as well. We have a great team, everyone’s bright and really interested in what they’re doing.
Why do you think our customers like Datamonitor Healthcare?
I think the transparency of our content is something that clients really appreciate. When we produce a piece of content, we’re open about how we have come to conclusions, the data sources we use are available and secondary research is referenced. In our forecasts, we state our assumptions and it’s it clear where data comes from. If clients aren’t clear, then they can get in contact with us and we answer their queries personally.
That’s another part of the job I enjoy; you get that interaction between the analyst and the client. By speaking to clients we also get an understanding of what they are interested in specifically, you get a better focus of what you’re doing and you can then tailor your content to what you know clients want to know.
What do you think your greatest achievement has been since working at Datamonitor Healthcare?
I don’t think there is just one, there are probably a couple of things that I’m quite proud of.
Obviously the diabetes content is a large area for us. Working with the primary research team from designing the questionnaire and then through to producing the treatment and forecast reports was something I enjoyed. It’s quite a long process but to go from start to finish is quite an achievement.
Also, I enjoyed working with some of our other analysts to produce a white paper last year on the ADA conference (see here). It was interesting to look at both late-phase and earlier phase candidates to understand where the market may be heading in the future.
What are you most excited about this year in the pharmaceutical market?
There are quite a few things happening in diabetes this year. The first Lantus biosimilars are expected in Europe this year so it will be interesting to see how they are received by the market and how they perform in the real world. There are also a few combination drugs that are the first of their kind so it will be good to see if and how they change the treatment algorithms.
I also like to keep an eye on what’s going on in terms of deals so hopefully it’ll be another exciting year of M&A too.
Outside work, what do you enjoy doing?
I’m really into sport. I like cricket and football, and because I’m north of the M25 I can say I’m almost a local and support Man United without being a ‘glory fan’! I used to be a part of a cricket and football team but I haven’t got around to joining one in London yet.
A big thank you to Rajan for taking the time to talk to us!
- If you’d like to keep up to date with what Rajan is up to this year you can follow him on twitter by clicking here.
- You can also read his full bio here.
If you’re interested in seeing more of what Rajan does at Datamonitor Healthcare please download some of our free pieces of content below:
- Webinar: Future Market Dynamics in Type 2 Diabetes
- Infographic: Future Market Dynamics in Type 2 Diabetes
- White Paper: ADA 2014 Conference Review